fbpx
RESEARCH

CRUNCHFISH: Rights issue to stay the course on extended timeline

Analys, Research

As discussed in our previous update, Crunchfish has now settled on a path forward for the...

Read More

GRANGEX: Emerging as Europe’s top DR concentrate developer

Analys, Research

With the dust settling after the acquisition of Sydvaranger and the updated DFS for Dannemora in...

Read More

MOTION DISPLAY: Strong gross margin driving another profitable quarter  

Analys, Research

MODI reported Q2’24 sales largely in line with last year, at SEK 7.4m compared to SEK 7.6m in...

Read More

PROLIGHT: Pre-validation readout in Q4 sets stage for multicenter trial in 2025

Analys, Research

Supported by the latest troponin data generated from whole blood samples on the final commercial...

Read More

NANEXA: NEX-22 Progress, Revaluation and Financing

Analys, Research

After initiating dosing of the first patient in June with Nanexa’s long-acting depot formulation...

Read More

CRUNCHFISH: Three avenues to address the strained financing

Analys, Research

While the commercialization of Crunchfish’s solution for offline payments has shown a longer...

Read More

Agtira AB: Big launch and a capital-light expansion in the cards

Analys, Research

In terms of financials, Q2 was largely a repeat of Q1, with one-off replanting and remediation...

Read More

GRANGEX: Updated DFS confirming viability to produce high-grade iron ore at Dannemora

Analys, Research

The announcement of the updated DFS for Dannemora showed, as expected, higher CAPEX and OPEX...

Read More